It’s 2023: Where is the At-Home IVD Testing Market Now?

June 13, 2023/by Bruce Carlson

The Home IVD testing market is not new, but it had primarily been limited to glucose and pregnancy testing. COVID-19 testing has opened the door for home infectious disease testing and more. The market is detailed in Kalorama’s latest report At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests), 2023 https://kaloramainformation.com/product/at-home-diagnostic-testing-markets-and-trends-covid-19-fob-glucose-hiv-and-other-tests-2023/ The global Home IVD testing market was […]

Despite Declines, COVID-19 Still a Large IVD Market

May 1, 2023/by Bruce Carlson

When a market declines in momentum, it’s easy to forget that it still contributes to the overall market. This is the case with COVID-19. Testmakers are separating revenues to be sure investors know the parts of their business growing and declining and what part is related to the now-endemic disease. However, this belies the fact […]

Hematology Grows, Driven by Decentralization

April 7, 2023/by Bruce Carlson

The global market for hematology testing, inclusive of analyzers/instruments and reagents, is valued at $5,655 million in 2022. This includes all commercial laboratory and hospital-based products, some research use products used in clinical laboratories, and OTC product sales (not test services). This is according to Kalorama’s latest on hematology IVD. The report indicates that decentralized […]

Growth in Molecular Diagnostics, Beyond COVID-19

February 6, 2023/by Bruce Carlson

COVID-19 is not over, but test sales are clearly on the decline, and IVD companies for the most part have adopted a focus on other test areas to beat the negative trend. Abbot, Roche, Hologic and Quest are among the diagnostic testing companies that have reported 2022 results with COVID-19 losses softened by gains in […]

NGS in Molecular Diagnostics

January 11, 2023/by Bruce Carlson

The first NGS system was approved for clinical use by the FDA only in 2013. Hence, the market segment is quite new, even though a significant industry exists for LDTs performed as testing services on NGS platforms by certified clinical labs. The current IVD market available in clinical sequencing consists largely of sales of NGS […]